Learn about our patients and the patient care provided by the Comprehensive Breast Program.
Family history remains on the National Cancer Institute’s list of risk factors for breast cancer, but what does it mean when cancer “runs in the family?"
A common anti-diabetes drug being tested in many clinical trials as an anti-cancer agent activated fat metabolism that promoted the survival of dormant breast cancer cells, suggesting that the drug has context-dependent effects on cancer cells.
Participating in clinical trials gives breast cancer patient Amy Visser-Lynch a new outlook on life.
In February 2013, Debra Beaupre was waiting to hear back from Harvard about graduate school. She never expected that she would begin an entirely different journey - treatment for breast cancer.
NCCC surgeons work together to offer new tissue-sparing and nipple-sparing surgery methods, same-day breast reconstruction, and follow-up care to help women find treatment that reflects their values.
NCCC recently installed a real-time monitoring system that allows technicians to monitor the patient as she holds a deep breath for 20 seconds so radiation is precisely targeted.